BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18311468)

  • 1. Chronic genital ulceration due to herpes simplex infection treated successfully with imiquimod.
    Bangsgaard N; Skov L
    Acta Derm Venereol; 2008; 88(2):202-3. PubMed ID: 18311468
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of hypertrophic herpes simplex genitalis in HIV-infected patient with topical imiquimod.
    Deza G; Martin-Ezquerra G; Curto-Barredo L; Villar García J; Pujol RM
    J Dermatol; 2015 Dec; 42(12):1176-8. PubMed ID: 26074211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recalcitrant hypertrophic herpes genitalis in HIV-infected patient successfully treated with topical imiquimod.
    Tandon S; Singh J; Sinha S; Sharma DP
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28261899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical imiquimod for acyclovir-unresponsive herpes simplex virus 2 infection.
    Gilbert J; Drehs MM; Weinberg JM
    Arch Dermatol; 2001 Aug; 137(8):1015-7. PubMed ID: 11493093
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical imiquimod treatment of aciclovir-resistant herpes simplex disease: case series and literature review.
    Perkins N; Nisbet M; Thomas M
    Sex Transm Infect; 2011 Jun; 87(4):292-5. PubMed ID: 21406577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled study.
    Schacker TW; Conant M; Thoming C; Stanczak T; Wang Z; Smith M
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3243-8. PubMed ID: 12234851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical presentation of genital herpes simplex (HSV-2) in two patients with chronic lymphocytic leukemia.
    Shim TN; Minhas S; Muneer A; Bunker CB
    Acta Derm Venereol; 2014 Mar; 94(2):246-7. PubMed ID: 23975187
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical characteristics of hypertrophic herpes simplex genitalis and treatment outcomes of imiquimod: a retrospective observational study.
    Leeyaphan C; Surawan TM; Chirachanakul P; Prasertworonun N; Punyaratabandhu P; Omcharoen V; Jiamton S
    Int J Infect Dis; 2015 Apr; 33():165-70. PubMed ID: 25660091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imiquimod 5% cream for the treatment of recurrent, acyclovir-resistant genital herpes.
    Brummitt CF
    Clin Infect Dis; 2006 Feb; 42(4):575. PubMed ID: 16421805
    [No Abstract]   [Full Text] [Related]  

  • 10. Vegetative chronic genital herpes with satisfactory response to imiquimod.
    Siqueira SM; Gonçalves BB; Loss JB; Estrella RR
    An Bras Dermatol; 2019; 94(2):221-223. PubMed ID: 31090830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imiquimod and genital herpes.
    Slade HB; Schacker T; Conant M; Thoming C
    Arch Dermatol; 2002 Apr; 138(4):534; author reply 534-5. PubMed ID: 11939822
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of oral acyclovir and imiquimod for the treatment of hypertrophic genital herpes simplex in HIV positive patients: report of two cases.
    Barbosa Ldo N; Souto R; Furtado AL; Gripp AC; Daxbacher E
    An Bras Dermatol; 2011; 86(5):1043-5. PubMed ID: 22147057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive and refractory genital herpes in human immunodeficiency virus-infected patient successfully treated with imiquimod: Case report and literature review.
    Camasmie HR; Barbosa C; Lupi O; Lima RB; Serra M; D'Acri AM; Martins CJ
    Indian J Dermatol Venereol Leprol; 2017; 83(2):256-259. PubMed ID: 28164895
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical imiquimod for recurrent acyclovir-resistant HSV infection.
    Martinez V; Molina JM; Scieux C; Ribaud P; Morfin F
    Am J Med; 2006 May; 119(5):e9-11. PubMed ID: 16651045
    [No Abstract]   [Full Text] [Related]  

  • 15. [Partial efficacy of imiquimod on plantar warts in immunodeficient patients].
    Dupin N; Soubrane O; Escande JP
    Ann Dermatol Venereol; 2003 Feb; 130(2 Pt 1):210-1. PubMed ID: 12671588
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical treatment of warts and mollusca with imiquimod.
    Hengge UR; Goos M; Arndt R
    Ann Intern Med; 2000 Jan; 132(1):95. PubMed ID: 10627266
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical imiquimod for the treatment of keratoacanthomas.
    Calista D; Morri M
    Eur J Dermatol; 2008; 18(5):590-1. PubMed ID: 18779106
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical imiquimod for recalcitrant facial flat warts.
    Schwab RA; Elston DM
    Cutis; 2000 Mar; 65(3):160-2. PubMed ID: 10738635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult cutaneous Langerhans cell histiocytosis responsive to topical imiquimod.
    Taverna JA; Stefanato CM; Wax FD; Demierre MF
    J Am Acad Dermatol; 2006 May; 54(5):911-3. PubMed ID: 16635684
    [No Abstract]   [Full Text] [Related]  

  • 20. Lip papillomatosis in immunodeficiency: therapy with imiquimod.
    Rinne D; Linhart C; Schöfer H
    Br J Dermatol; 2000 Jan; 142(1):196-7. PubMed ID: 10819559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.